![Ching Sung Hsu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ching Sung Hsu
Presidente presso Formosa Lithium Iron Oxide Corp.
Posizioni attive di Ching Sung Hsu
Società | Posizione | Inizio | Fine |
---|---|---|---|
Formosa Lithium Iron Oxide Corp. | Presidente | - | - |
Storia della carriera di Ching Sung Hsu
Precedenti posizioni note di Ching Sung Hsu
Società | Posizione | Inizio | Fine |
---|---|---|---|
TAIWAN LEADER BIOTECH CORP. | Direttore/Membro del Consiglio | 06/03/2009 | 30/03/2017 |
UBI PHARMA INC. | Direttore/Membro del Consiglio | 26/03/2015 | - |
UNITED BIOPHARMA INC | Direttore/Membro del Consiglio | 15/11/2013 | - |
CHANGS ASCENDING ENTERPRISE CO., LTD. | Direttore/Membro del Consiglio | - | - |
Formazione di Ching Sung Hsu
Feng Chia University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Taiwan | 7 |
Posizioni
Director/Board Member | 4 |
Undergraduate Degree | 1 |
Chairman | 1 |
Settori
Health Technology | 4 |
Producer Manufacturing | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
CHANGS ASCENDING ENTERPRISE CO., LTD. | Producer Manufacturing |
TAIWAN LEADER BIOTECH CORP. | Health Technology |
UBI PHARMA INC. | Health Technology |
Aziende private | 2 |
---|---|
United BioPharma, Inc.
![]() United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
Formosa Lithium Iron Oxide Corp. |
- Borsa valori
- Insiders
- Ching Sung Hsu
- Esperienza